Skip to content
Lakefront Boitherapeutics icon

Lakefront Boitherapeutics

LKFTStocksBiotechnologyBelgiumNasdaqUSD | EUR

Price

$29.72

Today

+0.7%

YTD

-8.9%

About

Galapagos NV - ADR is a global biotechnology firm committed to developing novel medicines with transformative potential in immunology, oncology and other indications. Operating within the robust biopharmaceutical industry, Galapagos NV is engaged in integrated drug discovery, leveraging proprietary novel compounds that offer promising therapeutic applications. Galapagos NV partnered with Gilead to work on the development and commercialization of Filgotinib which is used for rheumatoid arthritis and ulcerative colitis. Elevate your trading game by tracking the share price of GLPG by adding it to your eToro watchlist.

Price chart
Closing price history for LKFT (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)2.80
P/S (TTM)1.79
P/B (TTM)0.52
Market cap$1.94B
Cap tierSmall-cap
Industry avg P/E-2.16

Profitability

Gross margin97.45%
EBIT margin59.54%
Net margin16.05%
ROE20.22%
ROA16.62%

Earnings & Revenue

Revenue (TTM)$1.15B
Revenue growth (1Y)+285.5%
EPS (TTM)$10.53
Free cash flow$-189.89M
Total debt$7.27M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.53
Employees452
Next earnings11 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Lakefront Boitherapeutics (LKFT) | Dirk Kuyken